Fig. 2From: Effect of omalizumab for autoimmune progesterone dermatitis refractory to bilateral oophorectomy: a case reportIatrogenic cushing’s syndrome (left panel—at the time of Xolair initiation), followed by drastic weight loss off prednisone (right panel—approximately one year steroid free), patient photograph, consent obtainedBack to article page